Comparison of Chronic Intra-stent Condition after Resolute Zotarolimus-Eluting Stent Implantation with Dual versus Single Antiplatelet Therapy with Prasgrel

Comparison of Chronic Intra-stent Condition after Resolute Zotarolimus-Eluting Stent Implantation with Dual versus Single Antiplatelet Therapy with Prasgrel - Dual versus Single Antiplatelet Therapy with Prasgrel for R-ZES implantation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020421

Enrollment

160

Registered

2016-01-04

Start date

2015-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

single antiplateltet therapy of Prasgurel followed by 1 month Prasgurel+aspirin dual antiplatelet therapy 12 months prasgrel + aspirin dual antiplatelet therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with coronary artery disease who implanted Resolute zotarolimus-eluting stent by optical coherence tomograpy

Exclusion criteria

Exclusion criteria: Acute coronary syndrome Unprotected left main coronary artery disease Chronich renal dysfunction

Design outcomes

Primary

Measure	Time frame
9 months optical coherence tomography data (intra-stent thrombus, neointimal healing, etc)	—

Countries

Japan

Contacts

Public ContactMikio Yasui

Hyogo Prefectural Himeji Cardiovascular Center General Cordinaion Division

mikio_yasui@pref.hyogo.lg.jp079-293-3131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026